There are so many reasons to explore France’s Normandy coastline: The Côte d’Albâtre (Alabaster coast) is a stretch of chalk cliffs, like England’s white cliffs of Dover across The Channel, with ...
Batman Causes The Death Of Kite Mans Son! #shorts #batman #kiteman #dccomics #dcuniverse A Florida town and its very expensive legal fight to take boathouses from owners Poll delivers major blow to ...
CHICAGO (WLS) -- Four people are in custody after a man experiencing homelessness was stabbed to death outside of a downtown restaurant on Sunday morning, officials said. Chicago police said the man ...
Six people were in custody Monday afternoon, after a homeless man was stabbed to death in the Loop in downtown Chicago on Sunday morning. Police said, around 7:20 a.m. Sunday, an unidentified man was ...
Homayoun Ershadi, the Iranian architect-turned-actor who is best known internationally for his role in Marc Forster’s Afghanistan-set The Kite Runner, has died at the age of 78. Iran’s state news ...
Kite, an artificial intelligence (AI)-powered payments blockchain, rolled out its native token on Monday, generating significant trading volume on South Korean exchanges Upbit and Bithumb. The token ...
Gilead Sciences' Kite Pharma is doubling down on in vivo CAR-T, this time inking a deal worth up to $1.64 billion biobucks with Chinese biotech Pregene Biopharma. Kite has paid out $120 million ...
Minesto, a marine energy technology developer based in Sweden, is a winner of the 2025 Gizmodo Science Fair for deploying the first operational, megawatt-scale tidal energy kite in the Faroe Islands.
The round, co-led by General Catalyst and PayPal Ventures, brings the San Francisco-based startup’s cumulative funding to $33 million, according to an emailed announcement on Tuesday. Formerly known ...
Gilead Sciences has become the latest pharma to strengthen its in vivo cell therapy credentials this year, paying $350 million for CAR-T developer Interius BioTherapeutics. Integrating Interius into ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...